Paper Details

  1. Home
  2. Paper Details

Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.

Author: BiondiDavid, LimmrothVolker, PfeilJoop, SchwalenSusanne

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Preventive treatment with topiramate in patients with episodic migraine may reduce the risk of developing chronic forms of headache. In a pooled analysis of 3 trials, topiramate significantly reduced the number of headache days and the number of patients reporting an increase in headache days. It also reduced acute medication usage.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: The aim was to evaluate whether preventive treatment with topiramate in patients with episodic migraine reduces the risk of developing chronic forms of headache. BACKGROUND: Chronic forms of headache, including chronic migraine or medication overuse headache (MOH), are characterized by 1...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1526-4610.2007.00648.x

データ提供：米国国立医学図書館（NLM）

Topiramate: A Potential Tool for Preventing Chronic Headache

Chronic headaches, including chronic migraine and medication overuse headache (MOH), can significantly impact a person's quality of life. This study investigates the potential of topiramate, a medication commonly used for epilepsy, to prevent the development of chronic headaches in patients with episodic migraine.

The study found that preventive treatment with topiramate significantly reduced the number of headache days and the likelihood of developing chronic headaches. This suggests that topiramate could be a valuable tool for preventing chronic headache in patients with episodic migraine.

Topiramate: A Protective Shield Against Chronic Headaches

This research offers a glimmer of hope for patients struggling with episodic migraine. Topiramate's potential to prevent the development of chronic headache is a significant finding, offering a potentially life-changing treatment option.

Dr. Camel's Conclusion

The desert of chronic headache can be a lonely and isolating place. This research offers a ray of hope by demonstrating the potential of topiramate to prevent the development of chronic headache in patients with episodic migraine. Further research is needed to confirm these findings and explore the long-term benefits of this treatment approach.

Date :
  1. Date Completed 2007-04-17
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

17355489

DOI: Digital Object Identifier

10.1111/j.1526-4610.2007.00648.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.